| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/07/2011 | CN101503461B Polypeptide with liver cancer apoptosis reducing function |
| 09/07/2011 | CN101474344B Qi-moving dampness-drying spleen-strengthening medicament for sheep |
| 09/07/2011 | CN101468184B Medicament for treating digestive system cancer and preparation method thereof |
| 09/07/2011 | CN101468078B Chinese medicinal compound suppository for treating constipation and preparation method thereof |
| 09/07/2011 | CN101450046B Nizatidine freeze-dried powder injection and preparation method thereof |
| 09/07/2011 | CN101417105B Zedoary turmeric oil glucose injection and preparation method thereof |
| 09/07/2011 | CN101396428B Tibetan capillary extract and preparation method, medicine composition and use thereof |
| 09/07/2011 | CN101380461B Efficient thymosin enteric-coated tablets and thymosin for injection |
| 09/07/2011 | CN101328168B Diethylcarbamyl-substituted thiazole dihydropyrimidine |
| 09/07/2011 | CN101259125B Anethol trithione injection emulsion and preparation thereof |
| 09/07/2011 | CN101249097B Applications of ash tree flowers polysaccharide for preparing preventing and controlling pig virosis medicament |
| 09/07/2011 | CN101204200B Pet cat beverage additive and cat beverage thereof |
| 09/07/2011 | CN101194979B Powder medicament for treating herpes stomatitis |
| 09/07/2011 | CN101194956B Fumigation medicament for treating archoptosis |
| 09/07/2011 | CN101185664B Waxberry fruit extract, its preparation method and its application of protecting liver |
| 09/07/2011 | CN101156936B An administer orally mixed nucleus glycosides as well as its preparing technics |
| 09/07/2011 | CN101090643B Temporally meal menu for infants |
| 09/07/2011 | CN101066355B Chinese medicine prepn for treating toothache and its prepn process |
| 09/07/2011 | CN101011470B Traditional Chinese medicine compound composition for treating hepatitis |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8012997 Isoindole-imide compounds, compositions, and uses thereof |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | CA2701704C Process for producing crystal |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2488642C Aryl carbonyl derivatives as glucokinase activators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2415228C Treatment of bone diseases |
| 09/06/2011 | CA2396148C Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/01/2011 | WO2011106482A1 Formulations and methods for nutrient delivery |
| 09/01/2011 | WO2011105611A1 Ghrelin receptor agonist for treatment of dyscrasia |
| 09/01/2011 | WO2011105383A1 Agent for controlling production of primary bile acid and secondary bile acid |
| 09/01/2011 | WO2011104584A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | WO2011043564A3 Composition containing black ginseng extracts for preventing or treating liver cancer |
| 09/01/2011 | WO2011034362A3 Composition containing saururus chinensis extract or sauchinone as an active ingredient, for preventing and treating diseases caused by the overexpression of lxr-α |
| 09/01/2011 | WO2011017554A4 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110212999 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 09/01/2011 | US20110212998 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212963 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 09/01/2011 | US20110212962 P38 map kinase inhibitors |
| 09/01/2011 | US20110212960 New compounds for the treatment of cns disorder |
| 09/01/2011 | US20110212959 Cyanoisoquinoline Compounds and Methods of Use Thereof |
| 09/01/2011 | US20110212956 Pyrazolopyrimidines for treating CNS disorders |
| 09/01/2011 | US20110212952 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity |
| 09/01/2011 | US20110212943 Novel bridged cyclic compounds as histone deacetylase inhibitors |
| 09/01/2011 | US20110212941 Imidazoisoindole Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212916 Method and means for improving bowel health |
| 09/01/2011 | US20110212889 Use of leptin for the treatment of fatty liver diseases and conditions |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212881 Aleurone as a prebiotic fiber for improved intestinal health |
| 09/01/2011 | US20110212198 Hangover relief by compositions comprising oral rehydration solution |
| 09/01/2011 | US20110212189 Gastroretentive oral high dose zinc preparations |
| 09/01/2011 | US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended) |
| 09/01/2011 | US20110212165 Pharmaceutical compositions of the isolated d-enantiomer of the quinazolinone derivative halofuginone |
| 09/01/2011 | US20110212104 Inflammatory bowel disease biomarkers and related methods of treatment |
| 09/01/2011 | US20110212099 Methods of modulating il-22 and il-17 |
| 09/01/2011 | US20110212097 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212061 Mesoderm and Definitive Endoderm Cell Populations |
| 09/01/2011 | US20110212056 Combination therapy for the treatment of liver diseases |
| 09/01/2011 | US20110212052 Methods and compositions of treating and preventing autoimmune diseases |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | CA2791177A1 Formulations and methods for nutrient delivery |
| 09/01/2011 | CA2790993A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | CA2789750A1 Ghrelin receptor agonist for treatment of cachexia |
| 09/01/2011 | CA2787965A1 Oral care compositions |
| 08/31/2011 | EP2361902A1 4,6-diaminonicotinamide compound |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361623A1 Composition comprising a polyphenol salt and corresponding use |
| 08/31/2011 | EP2361620A1 Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome |
| 08/31/2011 | EP2361090A1 Compositions for treating centrally mediated nausea and vomiting |
| 08/31/2011 | EP2361087A1 Anti-inflammatory compounds and compositions thereof |
| 08/31/2011 | EP2214659B1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 08/31/2011 | EP2183027B1 Organic compounds |
| 08/31/2011 | EP2121683B1 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | EP1506000B9 Heterocyclicsulfonamide hepatitis c virus inhibitors |
| 08/31/2011 | EP1493441B1 Therapeutic agent for food competence disorder in stomach |
| 08/31/2011 | EP1443938B1 Dosage unit comprising a prostaglandin analog for treating constipation |
| 08/31/2011 | EP1339394B1 Pharmaceutical preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 08/31/2011 | CN1977924B Medicine for anti-liver fibrosis |
| 08/31/2011 | CN1895242B Diclofenac salt pleximetric paste and its production |
| 08/31/2011 | CN1830448B Aldfuwei ester injection having liver target and its preparation method |
| 08/31/2011 | CN1813984B Chinese medicine preparation for treating liver disease and preparing method |
| 08/31/2011 | CN1744896B Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist |
| 08/31/2011 | CN102170889A Pharmaceutical composition for preventing liver injury or improving liver function, containing the activated water of ENA actimineral resource A as an active ingredient |
| 08/31/2011 | CN102170877A Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers |
| 08/31/2011 | CN102167753A Preparation method of oat beta-glucan |
| 08/31/2011 | CN102167740A Fully human anti-VEGF (Vascular Endothelial Growth Factor) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN102167720A Betulonic acid derivant for restraining differentiation of osteoclast, preparation method thereof and application thereof |
| 08/31/2011 | CN102166338A Alpinia katsumadai-ginger composite, preparation method thereof and use thereof for preparing toxicity-attenuating and effect-increasing medicine for radiotherapy and chemotherapy of cancer |
| 08/31/2011 | CN102166336A Composition of loguat leaves and ginger as well as preparation method and application thereof to preparing toxicity reducing and efficacy enhancing medicines for radiotherapy and chemotherapy of cancers |
| 08/31/2011 | CN102166330A Medicament for treating hyperlipidemia and preparation thereof |
| 08/31/2011 | CN102166329A Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof |